Renowned Shoulder Surgeon Joins Osso VR Advisory Board
Contact Our Team
For more information about how Halldale can add value to your marketing and promotional campaigns or to discuss event exhibitor and sponsorship opportunities, contact our team to find out more
The Americas -
holly.foster@halldale.com
Rest of World -
jeremy@halldale.com
Osso VR has appointed Dr. Ken Yamaguchi, MBA, a shoulder surgeon and chief medical officer (CMO) at Centene Corporation, to the company’s advisory board.
Dr. Yamaguchi completed his residency training at George Washington University. He then completed fellowship training in shoulder surgery at the Shoulder Service at the Columbian Presbyterian Medical Center in New York, followed by supplemental training in elbow surgery at the Mayo Clinic. Dr. Yamaguchi founded and remains active in one of the top shoulder and elbow fellowships in the world. In 2012, Dr. Yamaguchi received his MBA from the Olin Business School at Washington University in St. Louis. In addition to his current role as CMO at Centene, Dr. Yamaguchi is the Sam & Marilyn Fox Distinguished Professor at Washington University.
“From top to bottom, we focused on pulling together the strongest team of clinical, medical device, technology and art experts from all over the globe, and we are extremely proud of what we’ve built together at Osso VR,” said Justin Barad, MD, CEO and co-founder of Osso VR. “We are extremely humbled to add Dr. Yamaguchi to our board and look forward to using his world-class expertise to scale our platform, reach more patients and ultimately allow medicine to thrive in the new normal.”
What are the latest trends in management systems for training? Find out in The Drive Towards Better Managed Training.
To build its clinically validated VR platform, Osso VR assembled a team of clinical, medical device and technology experts from leading institutions, including Apple, Industrial Light & Magic, Google, Microsoft, Sony, and Electronic Arts. Osso VR has attracted the best in medicine to form its advisory board, with healthcare leaders from Washington University, the Hospital for Special Surgery, Mayo Clinic, Harvard and Stanford.
